Carboplatin/Durvalumab/Nab-paclitaxel/Tremelimumab Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of carboplatin, durvalumab, nab-paclitaxel and tremelimumab that may be used in the treatment of non-small cell lung cancer (NSCLC).

**Synonyms:** - Carboplatin, nab-Paclitaxel, Durvalumab, Tremelimumab - Carboplatin-Durvalumab-Nab-paclitaxel-Tremelimumab - Carboplatin/Durvalumab/Nab-paclitaxel/Tremelimumab - Carboplatin/Durvalumab/Nab-paclitaxel/Tremelimumab-actl - Carboplatin/Imjudo/Abraxane/Imfinzi - Carboplatin/Imjudo/Nab-paclitaxel/Imfinzi - Imjudo/Imfinzi Plus Carboplatin/Nab-paclitaxel - Imjudo/Imfinzi/Carboplatin/Abraxane - Tremelimumab/Durvalumab/Albumin-bound Paclitaxel/Carboplatin - Tremelimumab/Durvalumab/Nab-paclitaxel/Carboplatin